A Falkirk-based biotech engineering company has secured more than £2.5m in funding to commercialise its bio-separation technology for pharmaceutical and food manufacturers.
Ufraction8 got the funding through a combination of private equity investment and grants to let it expand its existing facilities, grow its team, scale its technology, and deploy large-scale tests with prospective customers.
It hopes to make manufacturing more sustainable with its bio-separation instruments, designed to let more efficient engineering of bio-based products, including microalgae-based foods, mammalian cell-based drugs, or yeast-based products such as beer or medicines.
